Connect with us

Published

on

As the popularity of semaglutide weight loss medications continues to grow, so does the rate of potentially dangerous overdoses, experts are warning. 

Reported overdoses of semaglutide products such as Ozempic and Wegovy more than doubled between 2022 and 2023, according to Americas Poison Centers in Virginia.

“U.S. Poison Centers have documented 3,316 exposures to products containing semaglutide through Dec. 31, 2023, more than two times the number of cases reported in 2022,” Dr. Kait Brown, clinical managing director of Americas Poison Centers, told Fox News Digital via email.

“These cases include exposures to prescription semaglutide, compounded semaglutide and counterfeit semaglutide,” he said. 

“Most of these cases are associated with accidental therapeutic errors in adults.” Whats causing the overdoses?

Semaglutide medications are intended to be given in a low dose and increased slowly over a four-week period, according to Dr. Seth Kipnis, director of bariatic and robotic surgery at Hackensack Meridian Jersey Shore University Medical Center in Neptune, New Jersey. 7 Reported overdoses of Ozempic and Wegovy doubled between 2022 and 2023, according to Americas Poison Centers in Virginia. REUTERS

“If people jump right to the high dose, they will have more initial negative side effects,” he told Fox News Digital. 

In some cases, people who overdose may be getting the medication from a source other than a local doctor or taking someone else’s prescribed medication, the doctor noted.

People with a semaglutide prescription should follow the manufacturers and prescribing physician’s instructions, Kipnis advised.  7 This photo combo provided by the FDA shows an authentic Ozempic needle, left and a counterfeit needle, right. AP

“The dose is weekly,” he said. “If it is taken daily, it is too much.”

Dr. Maryann Amirshahi, co-medical director of the National Capital Poison Center in Washington, D.C., confirmed that there has been a large overall increase in semaglutide overdoses reported to poison centers nationally. 

“In addition, I have noticed a similar increase at my individual center,” Amirshahi, who is also professor of emergency medicine at the Georgetown University School of Medicine, told Fox News Digital. 7 Injection pens of Novo Nordisk’s weight-loss drug Wegovy are shown in this photo. REUTERS

The doctor attributes the increase to several factors, chiefly the “huge increase” in semaglutide prescribing.

“Secondarily, it is available in several different forms, which can cause confusion,” Amirshahi noted. 

“Ozempic is a dial-up pen with multiple doses while Wegovy is a single-dose pen.” 7 A person is seen injecting themselves with an Ozempic needle at their home. REUTERS

Another source of confusion is that many people are using compounded products. 

“Compounded versions have their own unique risks when it comes to a potential overdose, especially when theyre dispensed in multi-dose vials,” noted Alyssa Billingsley, PharmD, Missouri-based director of pharmacy content at GoodRx.

“These injections are often dispensed in vials, so theres a greater opportunity for dosing errors since youre measuring out your specific dose with a syringe,” she warned.  7 People who overdose may be getting the medication from a source other than a local doctor or taking someone else’s prescribed medication. REUTERS

“In some cases, the vial may contain as much as 10 times the amount of semaglutide as a single-use injection pen.” Warning signs and symptoms

The most commonly reported overdose symptoms include nausea, vomiting, abdominal pain, dizziness and diarrhea, Brown noted. 

“Some people have reported hypoglycemia (low blood sugar), which can be life-threatening,” she said.

Symptoms of low blood sugar include confusion, tremor, lightheadedness and palpitations, according to Amirshahi. 

“Semaglutide slows stomach emptying, which can lead to nausea, vomiting and abdominal pain,” she said.

In some cases, the stomach becomes almost paralyzed, a condition called gastroparesis, which can lead to dehydration, abnormal electrolytes and kidney damage, said Amirshahi.  7 Pens for the diabetes drug Ozempic sit on a production line. REUTERS

Another potential effect of semaglutide overdose is inflammation of the pancreas. 

“Symptoms of pancreatitis are very similar and can include nausea, vomiting, abdominal pain and dehydration,” Amirshahi noted. 

These signs and symptoms can also occur among patients taking normal doses of the medication as well as in overdoses, she added.

While any drug overdose can be serious, experts noted that taking too much semaglutide is rarely fatal. 

“Semaglutide is generally well-tolerated in overdose compared to other diabities medications,” Amirshahi said.

7 The most common overdose symptoms include nausea, vomiting, abdominal pain, dizziness and diarrhea.  REUTERS

However, for people who develop gastroparesis or pancreatitis, potential complications can include dehydration and kidney damage. 

“While low blood sugar is rare with semaglutide overdose, if it is not detected and treated early, it can lead to seizures,” Amirshahi added.

Kipnis noted that in terms of adverse effects, “anything is possible when an FDA-approved drug is taken inappropriately.” Start your day with all you need to know

Morning Report delivers the latest news, videos, photos and more. Enter your email address

Please provide a valid email address.

By clicking above you agree to the Terms of Use and Privacy Policy.

Thanks for signing up!
Never miss a story. Check out more newsletters What to do in an overdose event

Anyone who is taking a prescribed semaglutide should have a primary care physician or medical provider to provide close follow-up support, especially in the first several weeks as the dose increases, Kipnis advised. 

Although there is no specific antidote for a semaglutide overdose, the primary course of action is to treat the abdominal symptoms with nausea and pain medications, correct electrolytes, and give fluids for dehydration, said Amirshahi.

“We also treat the low blood sugar by giving glucose or dextrose,” she said. “The care is really supportive until the effects of the medication wear off.”

In some cases, it may be possible to manage symptoms at home after consulting with a health care professional, but other situations may require immediate medical attention, Billingsley noted. 

“For example, severe vomiting can result in serious dehydration and electrolyte imbalances, which can be dangerous if left untreated,” she told Fox News Digital. “Severe cases of hypoglycemia can also be life-threatening.”

To prevent an overdose, Billingsley said to make sure you feel comfortable and confident using the injection pen and selecting your specific dose. 

“Understand how often you should be injecting your dose, and consider using alarms, medication reminder apps, or other tools to help keep you on track,” she recommended. “Your pharmacist can be a helpful resource if any questions come up.”

For emergency assistance, call Poison Help at 1.800.222.1222 to speak with a poison expert or visit PoisonHelp.org for support and resources.

When contacted by Fox News Digital regarding the potential for overdoses, Novo Nordisk, maker of Ozempic and Wegovy, provided a statement.

“Novo Nodisk is the only company in the U.S. with FDA-approved products containing semaglutide, identified under the trade names Wegovy, Ozempic and RYBELSUS, and should only be prescribed after a close consultation between a health care provider and a patient and should only be taken under the supervision of a health care provider,” the company said.

It added, “Novo Nordisk stands behind the safety and efficacy of our FDA-approved semaglutide medicines when used as indicated and when taken under the care of a licensed health care professional.”

Continue Reading

Sports

Veteran pitcher Lynn retiring after 13-year career

Published

on

By

Veteran pitcher Lynn retiring after 13-year career

Longtime St. Louis Cardinals right-hander Lance Lynn announced Tuesday that he has retired from Major League Baseball after 13 seasons.

“Baseball season is upon us and I’m right here on the couch and that is where I’m gonna stay,” Lynn said on his wife’s podcast, “Dymin in the Rough.”

“I am officially retiring from baseball right here, right now.”

Lynn, 37, spent much of his career with the Cardinals (2011-17, 2024) but also has pitched for the Minnesota Twins (2018), New York Yankees (2018), Texas Rangers (2019-20), Chicago White Sox (2021-23) and Los Angeles Dodgers (2023).

Last season with the Cardinals, he started 23 games and had a 7-4 record with a 3.84 ERA, throwing 117⅓ innings and striking out 109.

The two-time All-Star has a career record of 143-99 with a 3.74 ERA in 364 games (340 starts), tossing 2,006⅓ innings. He ranks sixth in that category, as well as in wins, among active pitchers. Ahead of him in each category are three sure Hall of Famers — Justin Verlander, Max Scherzer and Clayton Kershaw.

Lynn, on Tuesday, made it clear that he may be spotted on the baseball field … just not in a major league game.

“There might be something a little fun around the corner upcoming weekend, so stayed tuned,” Lynn said. “But from Major League Baseball, I am done pitching.”

Continue Reading

Sports

Yanks bring back reliever Ottavino on 1-yr. deal

Published

on

By

Yanks bring back reliever Ottavino on 1-yr. deal

NEW YORK — Right-hander reliever Adam Ottavino is returning to the New York Yankees, agreeing Tuesday to a one-year contract.

A 39-year-old sidearmer, Ottavino agreed to a minor league contract with Boston on Feb. 18 and exercised his right to be released on March 23 after compiling a 10.80 ERA in five spring training appearances.

He was 2-2 with one save and a 4.34 ERA in 60 relief appearances for the New York Mets last year, stranding 15 of 20 inherited runners.

Ottavino pitched for the Yankees in 2019 and ’20, going 8-8 with a 2.76 ERA in 97 relief appearances. He is 41-43 with 46 saves and a 3.49 ERA in 14 big league seasons with St. Louis, Colorado (2012-18), the Yankees (2019-20), Boston (2021) and the Mets (2022-24).

The Yankees transferred right-hander JT Brubaker to the 60-day injured list and placed closer Devin Williams on the paternity list.

Continue Reading

Politics

Payouts for departing civil servants capped at £95,000 under voluntary exit scheme

Published

on

By

Payouts for departing civil servants capped at £95,000 under voluntary exit scheme

The most senior and long-serving civil servants could be offered a maximum of £95,000 to quit their jobs as part of a government efficiency drive.

Sky News reported last week that several government departments had started voluntary exit schemes for staff in a bid to make savings, including the Department for Environment and Rural Affairs, the Foreign Office and the Cabinet Office.

The Department for Health and Social Care and the Ministry of Housing and Local Government have yet to start schemes but it is expected they will, with the former already set to lose staff following the abolition of NHS England that was announced earlier this month.

Politics latest: PM admits cost of living crisis ‘ongoing’

Rachel Reeves, the chancellor, confirmed in last week’s spring statement that the government was setting aside £150m to fund the voluntary exit schemes, which differ from voluntary redundancy in that they offer departments more flexibility around the terms offered to departing staff.

Ms Reeves said the funding would enable departments to reduce staffing numbers over the next two years, creating “significant savings” on staff employment costs.

A maximum limit for departing staff is usually set at one month per year of service capped at 21 months of pay or £95,000.

More from Politics

Whitehall sources stressed the figure was “very much the maximum that could be offered” given that the average civil service salary is just over £30,000 per year.

Whitehall departments will need to bid for the money provided at the spring statement and match the £150m from their own budgets, bringing the total funding to £300m.

Please use Chrome browser for a more accessible video player

Spring statement 2025 key takeaways

The Cabinet Office is understood to be targeting 400 employees in a scheme that was announced last year and will continue to run over this year.

A spokesman said each application to the scheme would be examined on a case-by-case basis to ensure “we retain critical skills and experience”.

It is up to each government department to decide how they operate their scheme.

The voluntary exit schemes form part of the government’s ambition to reduce bureaucracy and make the state more efficient amid a gloomy economic backdrop.

Ahead of the spring statement, Ms Reeves announced plans to cut civil service running costs by 15% by 2030, which ministers have said will save £2.2bn.

Read more from Sky News:
Sentencing guidelines for ethnic minority suspects delayed
Major incident declared as ‘17,000 tonnes’ of rubbish piles up

The move could result in 10,000 civil service jobs being axed after numbers ballooned during the pandemic.

Ms Reeves hopes the cuts, which she said will be to “back office jobs” rather than frontline services, but civil service unions have raised concerns that government departments will inevitably lose skilled and experienced staff.

The cuts form part of a wider government agenda to streamline the civil service and the size of the British state, which Sir Keir Starmer criticised as “weaker than it has ever been”.

During the same speech, he announced that NHS England, the administrative body that runs the NHS, would also be scrapped to eliminate duplication and cut costs.

Continue Reading

Trending